{"id":2511,"date":"2016-09-23T08:30:50","date_gmt":"2016-09-23T08:30:50","guid":{"rendered":"http:\/\/www.compumedics.com.au\/?p=2511"},"modified":"2016-11-24T03:40:43","modified_gmt":"2016-11-24T03:40:43","slug":"successful-completion-of-6-5m-capital-raising","status":"publish","type":"post","link":"https:\/\/www.compumedics.com.au\/en\/blog\/successful-completion-of-6-5m-capital-raising\/","title":{"rendered":"SUCCESSFUL COMPLETION OF $6.5M CAPITAL RAISING"},"content":{"rendered":"<p><strong>Compumedics Limited (ASX: CMP) (\u201cCompumedics\u201d and \u201cCompany\u201d)<\/strong> \u2013 an international leader in medical devices for sleep, brain and ultrasonic blood-flow monitoring \u2013 is pleased to announce that it has successfully completed a $6.5m placement, which was announced to market on 21 September 2016.<\/p>\n<p>The placement comprised the issue of $4.5m of new shares in the Company and a $2.0m sell down of existing shares in Compumedics.<\/p>\n<p>The placement was undertaken at $0.54 per share (3.0% discount to the VWAP immediately prior to the trading halt) and within the Company\u2019s 15% placement capacity in accordance with ASX Listing Rule 7.1.<\/p>\n<p><strong>Dr David Burton, Executive Chairman of Compumedics, said:<\/strong><\/p>\n<p>\u201cWe are very pleased with the level and quality of support shown for the Company by this capital raising, which closed significantly oversubscribed.<\/p>\n<p>\u201cWe are also very grateful to our long-term supporting shareholders and are delighted to welcome our new institutional shareholders onto our share register.<\/p>\n<p>\u201cThis placement strengthens our balance sheet, providing greater flexibility to pursue the commercialisation of the current opportunities identified by Compumedics, whilst the sell-down improves the liquidity of the Company\u2019s tradable securities.\u201d<\/p>\n<p>PAC Partners served as sole lead managers for the capital raising.<\/p>\n<p>The new shares are scheduled to be issued on Monday, 26 September, 2016.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Compumedics Limited (ASX: CMP) (\u201cCompumedics\u201d and \u201cCompany\u201d) \u2013 an international leader in medical devices for sleep, brain and ultrasonic blood-flow monitoring \u2013 is pleased to announce that it has successfully completed a $6.5m placement, which was announced to market on [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[98],"tags":[],"class_list":["post-2511","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/posts\/2511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/comments?post=2511"}],"version-history":[{"count":0,"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/posts\/2511\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/media?parent=2511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/categories?post=2511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/tags?post=2511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}